Literature DB >> 6428788

Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa.

T Meshulam, N Obedeanu, D Merzbach, J D Sobel.   

Abstract

In order to evaluate the role of mucoid coating of clinical isolates of Pseudomonas aeruginosa as a virulence factor, opsonophagocytosis of mucoid and nonmucoid strains of P. aeruginosa were studied by three different methods: uptake of [3H]adenine-labeled bacteria, oxygen consumption, and chemiluminescence production by phagocytosing polymorphonuclear leukocytes. All three methods showed a strong correlation with regard to phagocytosis of the bacterial isolates. As a group, the mucoid strains of P. aeruginosa demonstrated significantly reduced phagocytic uptake by leukocytes when compared to nonmucoid strains, although occasionally mucoid strains did exhibit normal uptake. In vitro growth of mucoid strains under nonstationary conditions was associated with reduced mucoid coating and with a corresponding increase in susceptibility to leukocyte phagocytosis. Although the overall bactericidal activity of human polymorphonuclear leukocytes for mucoid strains was diminished, this appears to be a function of reduced ingestion since the rate of intracellular killing was similar for mucoid and nonmucoid strains. The enhanced susceptibility of mucoid strains to spontaneous bactericidal activity of pooled human serum was confirmed. Mucoid-producing strains produced less protease in vitro; however, the role of this phenomenon in influencing phagocytosis is unknown.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428788     DOI: 10.1016/0090-1229(84)90117-x

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  11 in total

Review 1.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

2.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.

Authors:  I Eichler; L Joris; Y P Hsu; J Van Wye; R Bram; R Moss
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

Review 3.  New perspectives in understanding and management of the respiratory disease in cystic fibrosis.

Authors:  S Suter
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

4.  Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase, specific monoclonal antibodies, and antibiotics.

Authors:  G T Mai; J G McCormack; W K Seow; G B Pier; L A Jackson; Y H Thong
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

Review 5.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 6.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

7.  Pseudomonas aeruginosa alginate promotes Burkholderia cenocepacia persistence in cystic fibrosis transmembrane conductance regulator knockout mice.

Authors:  Sangbrita S Chattoraj; Rachana Murthy; Shyamala Ganesan; Joanna B Goldberg; Ying Zhao; Marc B Hershenson; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2010-01-04       Impact factor: 3.441

8.  Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments.

Authors:  G T Mai; W K Seow; G B Pier; J G McCormack; Y H Thong
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

Review 9.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

10.  Immunization against Pseudomonas aeruginosa using Alg-PLGA nano-vaccine.

Authors:  Saeid Azimi; Leila Safari Zanjani
Journal:  Iran J Basic Med Sci       Date:  2021-04       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.